First in human phase I study of MK-2461, a small molecule inhibitor of c-Met, for patients with advanced solid tumors
Camacho L, Moulder S, LoRusso P, Blumenschein G, Bristow P, Kurzrock R, Fu S, Schlienger K, Bergstrom D. First in human phase I study of MK-2461, a small molecule inhibitor of c-Met, for patients with advanced solid tumors. Journal Of Clinical Oncology 2008, 26: 14657-14657. DOI: 10.1200/jco.2008.26.15_suppl.14657.Peer-Reviewed Original ResearchAdvanced solid tumorsHuman phase ISmall molecule inhibitorsSolid tumorsC-MetPhase IMolecule inhibitorsPatientsTumors